Kathrin Plitzko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kathrin Plitzko has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
- Aaron M. Armando
Department of Pharmacology, University of California San Diego, La Jolla, CA, USA
1 shared publication - Aditi Das
School of Chemistry and Biochemistry, College of Sciences Parker H. Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology Atlanta USA
1 shared publication - Ameer Y. Taha
Department of Food Science and Technology, College of Agriculture and Environmental Sciences, University of California, Davis, USA
1 shared publication - Anna Nicolaou
Laboratory for Lipidomics and Lipid Biology, Division of Pharmacy and Optometry, School of Health Sciences, The University of Manchester, Manchester, UK
1 shared publication - Anne Barden
Medical School, Royal Perth Hospital Unit, University of Western Australia, Perth, Australia
1 shared publication - Antonio Checa
Unit of Integrative Metabolomics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
1 shared publication
Latest Publications
- Top Cited Papers
- 20 May 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 18 (887) , eadw1245
Technical recommendations for analyzing oxylipins by liquid chromatography–mass spectrometry
Several oxylipins are potent lipid mediators that regulate diverse aspects of health and disease and whose quantitative analysis by liquid chromatography–mass spectrometry (LC-MS) presents substantial technical challenges. As members of the lipidomics community, we developed technical recommendations to ensure best practices when quantifying oxylipins by LC-MS.
- 20 May 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 18 (887) , eadw1245
Top Cited PapersTechnical recommendations for analyzing oxylipins by liquid chromatography–mass spectrometry
Several oxylipins are potent lipid mediators that regulate diverse aspects of health and disease and whose quantitative analysis by liquid chromatography–mass spectrometry (LC-MS) presents substantial technical challenges. As members of the lipidomics community, we developed technical recommendations to ensure best practices when quantifying oxylipins by LC-MS.